Presumed guilty: natural killer T cell defects and human disease

被引:286
作者
Berzins, Stuart P. [1 ]
Smyth, Mark J. [2 ]
Baxter, Alan G. [3 ]
机构
[1] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia
[2] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia
[3] James Cook Univ, Comparat Genom Ctr, Townsville, Qld 4811, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
INVARIANT NKT CELLS; AUTOIMMUNE DIABETES-MELLITUS; ANTIGEN-PRESENTING CELLS; ALPHA-GALACTOSYLCERAMIDE; CANCER-PATIENTS; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD; DENDRITIC CELLS; TUMOR-IMMUNITY; BONE-MARROW;
D O I
10.1038/nri2904
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer T (NKT) cells are important regulatory lymphocytes that have been shown in mouse studies, to have a crucial role in promoting immunity to tumours, bacteria and viruses, and in suppressing cell-mediated autoimmunity. Many clinical studies have indicated that NKT cell deficiencies and functional defects might also contribute to similar human diseases, although there is no real consensus about the nature of the NKT cell defects or whether NKT cells could be important for the diagnosis and/or treatment of these conditions. In this Review, we describe the approaches that have been used to analyse the NKT cell populations of various patient groups, suggest new strategies to determine how (or indeed, if) NKT cell defects contribute to human disease, and discuss the prospects for using NKT cells for therapeutic benefit.
引用
收藏
页码:131 / 142
页数:12
相关论文
共 108 条
  • [1] CD4+ invariant T-cell-receptor plus natural killer T cells in bronchial asthma.
    Akbari, O
    Faul, JL
    Hoyte, EG
    Berry, GJ
    Wahlström, J
    Kronenberg, M
    DeKruyff, RH
    Umetsu, DT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (11) : 1117 - 1129
  • [2] Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission
    Araki, M
    Kondo, T
    Gumperz, JE
    Brenner, MB
    Miyake, S
    Yamamura, T
    [J]. INTERNATIONAL IMMUNOLOGY, 2003, 15 (02) : 279 - 288
  • [3] Distinct homeostatic requirements of CD4+ and CD4- subsets of Vα24-invariant natural killer T cells in humans
    Baev, DV
    Peng, XH
    Song, LP
    Barnhart, JR
    Crooks, GM
    Weinberg, KI
    Metelitsa, LS
    [J]. BLOOD, 2004, 104 (13) : 4150 - 4156
  • [4] Natural Killer T Cells: An Unconventional T-Cell Subset with Diverse Effector and Regulatory Functions
    Balato, Anna
    Unutmaz, Derya
    Gaspari, Anthony A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (07) : 1628 - 1642
  • [5] CD169+ macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes
    Barral, Patricia
    Polzella, Paolo
    Bruckbauer, Andreas
    van Rooijen, Nico
    Besra, Gurdyal S.
    Cerundolo, Vincenzo
    Batista, Facundo D.
    [J]. NATURE IMMUNOLOGY, 2010, 11 (04) : 303 - U48
  • [6] The biology of NKT cells
    Bendelac, Albert
    Savage, Paul B.
    Teyton, Luc
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 : 297 - 336
  • [7] Working with NKT cells - pitfalls and practicalities
    Berzins, SP
    Smyth, MJ
    Godfrey, DI
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (04) : 448 - 454
  • [8] Systemic NKT cell deficiency in NOD mice is not detected in peripheral blood: implications for human studies
    Berzins, SP
    Kyparissoudis, K
    Pellicci, DG
    Hammond, KJ
    Sidobre, S
    Baxter, A
    Smyth, MJ
    Kronenberg, M
    Godfrey, DI
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (03) : 247 - 252
  • [9] Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples
    Berzins, SP
    Cochrane, AD
    Pellicci, DG
    Smyth, MJ
    Godfrey, DI
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (05) : 1399 - 1407
  • [10] Signaling for NKT cell development: the SAP-FynT connection
    Borowski, C
    Bendelac, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (06) : 833 - 836